2026-2034年全球光分離療法產品市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，照光治療產品市場規模將達到 6.147 億美元，高於 2025 年的 3.7,643 億美元，預計從 2026 年到 2034 年，複合年成長率將達到 5.6%。

由於免疫相關疾病的日益普遍以及先進治療方法的廣泛應用，全球照光治療市場正蓬勃發展。照光治療廣泛用於治療移植物抗宿主疾病和某些自體免疫疾病等。人們對這些治療方法的認知不斷提高，以及對有效治療方法的需求不斷成長，正在推動市場成長。此外，醫療技術的進步也提高了光照光治療的效率和可近性。

推動成長的因素包括醫療保健投資的增加和免疫療法研究的拓展。隨著全球器官移植數量的增加，照光治療的需求顯著上升。設備和治療方案的技術進步改善了患者的治療效果並縮短了治療時間。此外，已開發地區優惠的報銷政策促進了光療的普及，而新興經濟體醫療基礎設施的完善則擴大了市場覆蓋範圍。

未來幾年，在持續創新和臨床應用範圍不斷擴大的推動下，照光治療產品市場預計將迎來顯著成長。個人化醫療和免疫療法的研究可望進一步拓展照光治療的應用範圍。先進技術和自動化技術在治療系統中的應用將提升治療效率和可近性。隨著人們對光療的認知不斷提高，醫療保健投資持續成長，新興市場可望湧現更多充滿機會的商機。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球光分離療法產品市場：依產品類型分類

• 市場分析、洞察與預測
• 開放系統
• 封閉式系統

第5章 全球光分離療法產品市場：依應用領域分類

• 市場分析、洞察與預測
• 移植物抗宿主疾病
• 皮膚T細胞淋巴瘤
• 移植排斥
• 自體免疫疾病

第6章 全球光分離療法產品市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 門診治療
• 其他

第7章 全球光分離療法產品市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Fresenius Kabi AG
  • Macopharma
  • Mallinckrodt
  • PIT Medical Systems
  • Terumo Corporation
  • Therakos, Inc.（a Johnson & Johnson Company）
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Asahi Kasei Medical Co.Ltd

The Photopheresis Products Market size is expected to reach USD 614.70 Million in 2034 from USD 376.43 Million (2025) growing at a CAGR of 5.6% during 2026-2034.

The global photopheresis products market is gaining momentum due to the increasing prevalence of immune-related disorders and the growing adoption of advanced therapeutic procedures. Photopheresis is widely used in treating conditions such as graft-versus-host disease and certain autoimmune diseases. The rising awareness about these therapies and the growing need for effective treatment options are driving market growth. Additionally, advancements in medical technologies are enhancing the efficiency and accessibility of photopheresis procedures.

Growth drivers include increasing healthcare investments and expanding research in immunotherapy. The rising number of organ transplants worldwide has significantly increased the demand for photopheresis treatments. Technological advancements in devices and treatment protocols are improving patient outcomes and reducing treatment time. Moreover, favorable reimbursement policies in developed regions are encouraging adoption, while growing healthcare infrastructure in emerging economies is expanding market reach.

In the coming years, the photopheresis products market is expected to witness significant growth due to ongoing innovations and increasing clinical applications. Research in personalized medicine and immunotherapy is likely to expand the scope of photopheresis treatments. The integration of advanced technologies and automation in treatment systems will enhance efficiency and accessibility. Emerging markets are expected to offer lucrative opportunities as awareness and healthcare investments continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Open System
• Closed System

By Application

• Graft Versus Host Disease
• Cutaneous T-Cell Lymphoma
• Transplant Rejections
• Autoimmune Diseases

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Care
• Others

COMPANIES PROFILED

• Fresenius Kabi AG, Macopharma, Mallinckrodt, PIT Medical Systems, Terumo Corporation, Therakos, Inc a Johnson Johnson company, Haemonetics Corporation, Miltenyi Biotec, Cerus Corporation, Asahi Kasei Medical Co, Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Open System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Closed System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Graft Versus Host Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cutaneous T-Cell Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transplant Rejections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHOTOPHERESIS PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fresenius Kabi AG
  • 9.2.2 Macopharma
  • 9.2.3 Mallinckrodt
  • 9.2.4 PIT Medical Systems
  • 9.2.5 Terumo Corporation
  • 9.2.6 Therakos, Inc. (a Johnson & Johnson Company)
  • 9.2.7 Haemonetics Corporation
  • 9.2.8 Miltenyi Biotec
  • 9.2.9 Cerus Corporation
  • 9.2.10 Asahi Kasei Medical Co.Ltd